Solid Biosciences (SLDB) Competitors $6.05 +0.09 (+1.46%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLDB vs. TWST, HROW, ABCL, IMCR, DYN, COGT, PAHC, EWTX, BHVN, and VCELShould you be buying Solid Biosciences stock or one of its competitors? The main competitors of Solid Biosciences include Twist Bioscience (TWST), Harrow (HROW), AbCellera Biologics (ABCL), Immunocore (IMCR), Dyne Therapeutics (DYN), Cogent Biosciences (COGT), Phibro Animal Health (PAHC), Edgewise Therapeutics (EWTX), Biohaven (BHVN), and Vericel (VCEL). These companies are all part of the "pharmaceutical products" industry. Solid Biosciences vs. Its Competitors Twist Bioscience Harrow AbCellera Biologics Immunocore Dyne Therapeutics Cogent Biosciences Phibro Animal Health Edgewise Therapeutics Biohaven Vericel Solid Biosciences (NASDAQ:SLDB) and Twist Bioscience (NASDAQ:TWST) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations. Which has stronger earnings & valuation, SLDB or TWST? Solid Biosciences has higher earnings, but lower revenue than Twist Bioscience. Twist Bioscience is trading at a lower price-to-earnings ratio than Solid Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolid BiosciencesN/AN/A-$124.70M-$2.80-2.16Twist Bioscience$362.27M5.01-$208.73M-$1.45-20.76 Which has more volatility & risk, SLDB or TWST? Solid Biosciences has a beta of 2.53, suggesting that its share price is 153% more volatile than the S&P 500. Comparatively, Twist Bioscience has a beta of 2.38, suggesting that its share price is 138% more volatile than the S&P 500. Is SLDB or TWST more profitable? Solid Biosciences has a net margin of 0.00% compared to Twist Bioscience's net margin of -23.51%. Twist Bioscience's return on equity of -29.03% beat Solid Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Solid BiosciencesN/A -69.70% -56.74% Twist Bioscience -23.51%-29.03%-21.77% Does the media prefer SLDB or TWST? In the previous week, Twist Bioscience had 24 more articles in the media than Solid Biosciences. MarketBeat recorded 29 mentions for Twist Bioscience and 5 mentions for Solid Biosciences. Solid Biosciences' average media sentiment score of 0.75 beat Twist Bioscience's score of 0.24 indicating that Solid Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solid Biosciences 0 Very Positive mention(s) 3 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Twist Bioscience 12 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer SLDB or TWST? Solid Biosciences presently has a consensus target price of $15.00, suggesting a potential upside of 148.06%. Twist Bioscience has a consensus target price of $48.50, suggesting a potential upside of 61.16%. Given Solid Biosciences' stronger consensus rating and higher probable upside, research analysts clearly believe Solid Biosciences is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solid Biosciences 1 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.92Twist Bioscience 2 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.58 Do insiders and institutionals have more ownership in SLDB or TWST? 81.5% of Solid Biosciences shares are held by institutional investors. 1.9% of Solid Biosciences shares are held by insiders. Comparatively, 3.0% of Twist Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummarySolid Biosciences beats Twist Bioscience on 10 of the 16 factors compared between the two stocks. Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLDB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLDB vs. The Competition Export to ExcelMetricSolid BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$470.87M$3.34B$6.05B$10.45BDividend YieldN/A2.31%5.73%4.79%P/E Ratio-2.1622.2585.3627.06Price / SalesN/A419.31583.22188.54Price / CashN/A44.9825.7330.17Price / Book1.7610.4112.686.69Net Income-$124.70M-$52.31M$3.31B$276.12M7 Day Performance10.35%0.67%-0.39%-1.29%1 Month Performance12.19%13.90%8.76%6.30%1 Year Performance-0.05%28.53%76.60%34.03% Solid Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLDBSolid Biosciences2.7347 of 5 stars$6.05+1.5%$15.00+148.1%-1.5%$470.87MN/A-2.16100Analyst UpgradeTWSTTwist Bioscience3.7674 of 5 stars$29.73+1.6%$48.90+64.5%-29.9%$1.79B$312.97M-20.45990HROWHarrow2.6736 of 5 stars$48.22-0.3%$68.50+42.1%-26.1%$1.78B$199.61M-192.86180ABCLAbCellera Biologics2.3881 of 5 stars$5.97+0.1%$8.00+34.1%+113.5%$1.78B$28.83M-10.85500Positive NewsIMCRImmunocore2.4317 of 5 stars$35.32-1.7%$56.89+61.1%+4.2%$1.78B$310.20M-88.30320DYNDyne Therapeutics3.5562 of 5 stars$12.47-0.3%$34.07+173.3%-58.3%$1.77BN/A-3.23100Analyst DowngradeCOGTCogent Biosciences1.7926 of 5 stars$14.39+1.8%$20.00+39.0%+44.6%$1.64BN/A-8.0880PAHCPhibro Animal Health4.3498 of 5 stars$39.93-2.1%$28.40-28.9%+54.9%$1.62B$1.30B33.842,475Analyst RevisionEWTXEdgewise Therapeutics2.5923 of 5 stars$15.17-1.8%$38.83+156.0%-52.7%$1.60BN/A-9.7860BHVNBiohaven2.9298 of 5 stars$15.05+1.6%$48.85+224.6%-70.4%$1.59BN/A-1.96239VCELVericel3.0342 of 5 stars$30.92+0.0%$60.40+95.3%-23.6%$1.56B$237.22M257.60300 Related Companies and Tools Related Companies Twist Bioscience Competitors Harrow Competitors AbCellera Biologics Competitors Immunocore Competitors Dyne Therapeutics Competitors Cogent Biosciences Competitors Phibro Animal Health Competitors Edgewise Therapeutics Competitors Biohaven Competitors Vericel Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLDB) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
